Does RUCAPARIB CAMSYLATE Cause Neuropathy peripheral? 224 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 224 reports of Neuropathy peripheral have been filed in association with RUCAPARIB CAMSYLATE (Rubraca). This represents 2.7% of all adverse event reports for RUCAPARIB CAMSYLATE.
224
Reports of Neuropathy peripheral with RUCAPARIB CAMSYLATE
2.7%
of all RUCAPARIB CAMSYLATE reports
0
Deaths
31
Hospitalizations
How Dangerous Is Neuropathy peripheral From RUCAPARIB CAMSYLATE?
Of the 224 reports, 31 (13.8%) required hospitalization.
Is Neuropathy peripheral Listed in the Official Label?
Yes, Neuropathy peripheral is listed as a known adverse reaction in the official FDA drug label for RUCAPARIB CAMSYLATE.
What Other Side Effects Does RUCAPARIB CAMSYLATE Cause?
Fatigue (2,494)
Nausea (2,219)
Malignant neoplasm progression (1,162)
Decreased appetite (787)
Constipation (763)
Diarrhoea (759)
Vomiting (759)
Asthenia (660)
Adverse event (571)
Carbohydrate antigen 125 increased (562)
What Other Drugs Cause Neuropathy peripheral?
LENALIDOMIDE (10,215)
BORTEZOMIB (4,067)
OXALIPLATIN (3,662)
DEXAMETHASONE (3,543)
PACLITAXEL (3,508)
LEVOFLOXACIN (2,619)
CIPROFLOXACIN (2,607)
FLUOROURACIL (2,605)
CYCLOPHOSPHAMIDE (2,565)
POMALIDOMIDE (2,382)
Which RUCAPARIB CAMSYLATE Alternatives Have Lower Neuropathy peripheral Risk?
RUCAPARIB CAMSYLATE vs RUFINAMIDE
RUCAPARIB CAMSYLATE vs RUPATADINE
RUCAPARIB CAMSYLATE vs RUXOLITINIB
RUCAPARIB CAMSYLATE vs SABRIL
RUCAPARIB CAMSYLATE vs SACCHAROMYCES CEREVISIAE